On September 30, 2025, Predictive Oncology Inc. (NASDAQ: POAI) announced the pricing of two private placement transactions that will raise a total of approximately $344.4 million. The deal consists of a Cash PIPE that will issue about 66.7 million shares of common stock at an offering price of $0.7751 per share, generating gross cash proceeds of roughly $51.7 million, and a Crypto PIPE that will issue pre‑funded warrants to purchase up to 223.6 million shares of common stock, with a notional value of $292.7 million (equivalent to $173.3 million in discounted value).
The Cash PIPE and Crypto PIPE are expected to close concurrently on or about October 2, 2025, subject to customary closing conditions. The pre‑funded warrants in the Crypto PIPE will become exercisable immediately after shareholder approval of the warrants’ exercise. DNA Holdings Venture, Inc. will serve as the strategic advisor and consultant for the digital asset treasury strategy, while H.C. Wainwright & Co. will act as the exclusive placement agent for the Cash PIPE. The company also announced that the reverse stock split approved on September 19, 2025 will become effective at 12:01 a.m. on September 30, 2025.
The company plans to use the net proceeds primarily to fund the acquisition of ATH, the native utility token of the Aethir ecosystem, and to support its digital asset treasury strategy. Remaining proceeds will be allocated to working capital and general corporate purposes. By holding ATH tokens, Predictive Oncology aims to leverage Aethir’s decentralized GPU network to secure enterprise‑grade AI infrastructure at a significant cost advantage, thereby strengthening its core AI‑driven drug discovery platform. The move also positions the company to operate as an operator on the Aethir ecosystem, potentially creating a strategic compute reserve that could generate additional revenue streams.
The announcement underscores Predictive Oncology’s pivot toward integrating blockchain‑enabled infrastructure with its existing AI and biobank assets. The dual‑PIPE structure—combining traditional equity with crypto‑token‑backed warrants—reflects the company’s ambition to diversify its capital base while aligning with emerging digital asset markets. This financing event is a material development for investors, as it provides the capital necessary to sustain operations, pursue new technology initiatives, and address liquidity concerns highlighted in prior financial disclosures.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.